Human Papillomavirus Epidemiology Forecast to 2030 By Delveinsight

Posted on
by

Human Papillomavirus Epidemiology Forecast to 2030 By Delveinsight

(Albany, US) DelveInsight has launched a new report on Human Papillomavirus Epidemiology

 

DelveInsight’s Human Papillomavirus Epidemiology Forecast to 2030 report delivers an in-depth understanding of the disease, historical and forecasted Human Papillomavirus (HPV) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Human Papillomavirus is the most common DNA virus that causes infection in the epithelial cells of skin and mucosa. The moist epithelial surfaces (squamous cells) include all areas covered by skin and/or mucosae such as the mouth interior, throat, tongue, tonsils, vagina, cervix, vulva, penis (the urethra – the opening), and anus. Contact of the areas mentioned above with a virus leads to the transmission of the virus, allowing it to transfer between epithelial cells. While it is known that sexual contacts, both conventional and oral, are the means of transferring HPV through direct skin to skin contact, other possible pathways for the transfer of virus are still poorly known. HPV can cause cervical and other cancers, including cancer of the vulva, vagina, penis, or anus. It can also cause cancer in the back of the throat, including the base of the tongue and tonsils (called oropharyngeal cancer). Cancer often takes years, even decades, to develop after a person gets HPV. Additionally, the types of HPV, which can cause genital warts, are not the same as the types of HPV that cause cancers.

 

 

Request for free sample page: – https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-epidemiology-forecast

 

Human Papillomavirus Epidemiology Perspective by DelveInsight

The Human Papillomavirus (HPV) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Human Papillomavirus (HPV) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Human Papillomavirus (HPV) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

 

Human Papillomavirus Epidemiology

The Human Papillomavirus epidemiology covered in the report provides historical as well as forecasted Human Papillomavirus (HPV) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030. The DelveInsight Human Papillomavirus (HPV) report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

 

Key facts of the report

  • As per the Center for Disease Control and Prevention (CDC), males are found to be more prevalent than females for both oral and genital HPV.
  • According to the National Health and Nutrition Examination, every day in the US, about 12,000 people of ages 15–24 are infected with HPV.
  • According to a study conducted by McQuillan et al. (2017), the prevalence of any oral human papillomavirus (HPV) for adults aged between 18 and 69 and high-risk HPV was 7.3% and 4.0%, respectively, from 2011 to 2014.
  • As per a study titled “Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types,” by Tanton et al. (2017), for all types, the prevalence was higher in the younger women (aged 16–20 and 21–24 years) than in those aged 25 or over.
  • As per a study titled “Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer,” by Onuki et al. (2009), HPV prevalence was found to be <25% in women with normal cytology, also, a total of 20 types were detected in women with normal cytology, and the number of detected genotypes decreased according to disease severity.

 

Scope of the Report

  • The Human Papillomavirus (HPV) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Human Papillomavirus (HPV) Epidemiology Report and Model provide an overview of the risk factors and global trends of Human Papillomavirus (HPV) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Human Papillomavirus (HPV) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Human Papillomavirus (HPV)
  • The report provides the segmentation of the Human Papillomavirus (HPV) epidemiology

 

Request for free sample page: – https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-epidemiology-forecast

 

Table of content

1. Key Insights 

2. Executive Summary of Human Papillomavirus (HPV)

3. Human Papillomavirus (HPV): Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. KOL Views

8. Unmet Needs

9.  Appendix

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

 

Why should you buy this report?

  • The Human Papillomavirus (HPV) Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Human Papillomavirus (HPV) market
  • Quantify patient populations in the global Human Papillomavirus (HPV) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Human Papillomavirus (HPV) therapeutics in each of the markets covered
  • Understand the magnitude of Human Papillomavirus (HPV) population by its epidemiology
  • The Human Papillomavirus (HPV) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources.

 

Related Reports

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/